Lucas Brent T.'s Form 4 filing
Envoy Medical, Inc. (COCH) · filed Nov 24, 2023
- Accession no.
- 0001062993-23-021438
- Filed
- Nov 24, 2023
- Trade date
- Nov 21, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $12.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lucas Brent T.CIK 0001994382 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 21, 2023 | Class A Common Stock | PPurchaseAcquired | +10,000 | $0.98 | +$9,800 | 118,451 | Direct | |
| Nov 21, 2023 | Class A Common Stock | PPurchaseAcquired | +2,380 | $0.92 | +$2,189.6 | 120,831 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.